Reinsurance Group of America, Inc. (RGA)
Reinsurance Group (RGA) Reports Next Week: Wall Street Expects Earnings Growth
Reinsurance Group (RGA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Investors Undervaluing Reinsurance Group of America (RGA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Reinsurance Group (RGA) Beat Estimates Again in Its Next Earnings Report?
Reinsurance Group (RGA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Reinsurance Group Of America: A Solid Buy With Growth Momentum
Reinsurance Group of America (RGA) is a global leader in life and health reinsurance that provides reinsurance solutions to life and health insurance companies. RGA's Q3'24 results beat expectations driven by strong ROE of 15.55, and significant premium growth, especially in Traditional business. Key highlights from the quarter included a $1.5 billion retrocession recapture, exclusive transactions in Asia, and a significant U.S. deal with American National, enhancing growth prospects.
Is Reinsurance Group of America (RGA) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
RGA Stock Trading at Discount to Industry at 1.24X: Time to Hold?
Reinsurance Group gains from new business volumes, favorable longevity experience, a diversified business, effective capital deployment and higher return on capital.
Should Value Investors Buy Reinsurance Group of America (RGA) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Reinsurance Group (RGA) Upgraded to Buy: Here's What You Should Know
Reinsurance Group (RGA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Are Investors Undervaluing Reinsurance Group of America (RGA) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Reinsurance Group Stock Rises 41.6% YTD: Will the Rally Last?
New business volumes, favorable longevity experience, a diversified business, effective capital deployment and higher return on capital poise RGA for growth.
Reinsurance Group of America: Best In Industry But High Valuation
Reinsurance Group of America has thrived on strong underwriting performance, pension-risk transfer, and longevity markets, with a 43% YTD stock increase and a 17% average annual return over the past decade. Its niche focus on life and health reinsurance, coupled with a conservative investment strategy, supports long-term stability but suggests limited near-term upside. Despite the impressive performance, RGA warrants a Hold rating due to elevated valuation metrics, risk profile, and a conservative price target range of $200–$220.
